Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malaria

Adherence of parasitized erythrocytes to activated endothelium causes microvascular obstruction, tissue ischemia, and clinical complications in severe malaria (SM); however, the mechanisms leading to endothelial activation remain unclear. The angiogenic factors, angiopoietin-2 (Ang-2) and vascular endothelial growth factor (VEGF) are modulators of endothelial activation, with Ang-2 release from Weibel–Palade bodies (WPBs) being regulated by endothelial nitric oxide (NO). We explored the relationships between endothelial NO bioavailability, Ang-2, VEGF, tissue perfusion, and clinical outcomes in SM. We measured plasma Ang-2 and VEGF, together with biomarkers of severity from 146 adults with and without SM, in parallel with longitudinal measures of endothelial function by using reactive hyperemia peripheral arterial tonometry (a measure of endothelial NO bioavailability). Regression was used to relate concentrations of Ang-2/VEGF with malaria disease severity, biomarkers of perfusion, endothelial activation, and parasite biomass. The longitudinal relationship between Ang-2 and endothelial function was assessed by using a mixed-effects model. Ang-2 concentrations were elevated in SM and associated with increased venous lactate, plasma intercellular cell adhesion molecule-1 concentrations, parasite biomass, and mortality. In contrast, VEGF concentrations were inversely associated with these biomarkers. Ang-2 concentrations were significantly better predictors of death than venous lactate (P = 0.03). Recovery of endothelial function was associated with falling concentrations of Ang-2. Ang-2 release from endothelial cells with reduced NO bioavailability is likely to contribute to endothelial activation, sequestered parasite biomass, impaired perfusion, and poor outcome in severe falciparum malaria. Agents that improve endothelial NO, reduce WPB exocytosis, and/or antagonize Ang-2 may have therapeutic roles in SM.

[1]  R. Price,et al.  Recovery of endothelial function in severe falciparum malaria: relationship with improvement in plasma L-arginine and blood lactate concentrations. , 2008, The Journal of infectious diseases.

[2]  R. Price,et al.  Malaria morbidity in Papua Indonesia, an area with multidrug resistant Plasmodium vivax and Plasmodium falciparum , 2008, Malaria Journal.

[3]  R. Ned,et al.  Malaria Journal Plasma Ip-10, Apoptotic and Angiogenic Factors Associated with Fatal Cerebral Malaria in India , 2008 .

[4]  D. Ferguson,et al.  Host vascular endothelial growth factor is trophic for Plasmodium falciparum-infected red blood cells. , 2008, Asian Pacific journal of allergy and immunology.

[5]  L. Guillot,et al.  Regulation of angiopoietin expression by bacterial lipopolysaccharide. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[6]  Barnes Kitsao,et al.  High levels of erythropoietin are associated with protection against neurological sequelae in African children with cerebral malaria , 2008, Proceedings of the National Academy of Sciences.

[7]  C. Ince,et al.  Direct in vivo assessment of microcirculatory dysfunction in severe falciparum malaria. , 2008, The Journal of infectious diseases.

[8]  J. Carcillo,et al.  ADMISSION ANGIOPOIETIN LEVELS IN CHILDREN WITH SEPTIC SHOCK , 2007, Shock.

[9]  D. Gowda.  TLR-mediated cell signaling by malaria GPIs. , 2007, Trends in parasitology.

[10]  R. Price,et al.  Impaired nitric oxide bioavailability and l-arginine–reversible endothelial dysfunction in adults with falciparum malaria , 2007, The Journal of experimental medicine.

[11]  P. D. de Groot,et al.  Thrombocytopenia and release of activated von Willebrand Factor during early Plasmodium falciparum malaria. , 2007, The Journal of infectious diseases.

[12]  P. Kubes,et al.  Differential Roles of CD36, ICAM‐1, and P‐selectin in Plasmodium falciparum Cytoadherence In Vivo , 2007, Microcirculation.

[13]  A. Ivens,et al.  Altered phenotype and gene transcription in endothelial cells, induced by Plasmodium falciparum-infected red blood cells: Pathogenic or protective? , 2007, International journal for parasitology.

[14]  C. Lowenstein,et al.  Pathogen Recognition by Toll-like Receptor 2 Activates Weibel-Palade Body Exocytosis in Human Aortic Endothelial Cells* , 2007, Journal of Biological Chemistry.

[15]  T. Rabelink,et al.  Endothelial function and dysfunction: testing and clinical relevance. , 2007, Circulation.

[16]  R. Price,et al.  Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison , 2007, The Lancet.

[17]  C. Roussos,et al.  Angiopoietin‐2 is increased in severe sepsis: Correlation with inflammatory mediators , 2007, Critical care medicine.

[18]  H. Augustin,et al.  Angiopoietins: a link between angiogenesis and inflammation. , 2006, Trends in immunology.

[19]  Susan Lewallen,et al.  Malarial retinopathy: a newly established diagnostic sign in severe malaria. , 2006, The American journal of tropical medicine and hygiene.

[20]  Marie Gerhard-Herman,et al.  Role of nitric oxide in the regulation of digital pulse volume amplitude in humans. , 2006, Journal of applied physiology.

[21]  P. Carmeliet,et al.  Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality , 2006, The Journal of experimental medicine.

[22]  A. Craig,et al.  von Willebrand factor propeptide in malaria: evidence of acute endothelial cell activation , 2006, British journal of haematology.

[23]  D. Sullivan,et al.  Plasmodium falciparum-Infected Erythrocytes Increase Intercellular Adhesion Molecule 1 Expression on Brain Endothelium through NF-κB , 2006, Infection and Immunity.

[24]  M. Rondaij,et al.  Dynamics and Plasticity of Weibel-Palade Bodies in Endothelial Cells , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[25]  H. Augustin,et al.  Angiopoietin-2 sensitizes endothelial cells to TNF-α and has a crucial role in the induction of inflammation , 2006, Nature Medicine.

[26]  M. Yamakuchi,et al.  Regulation of Weibel-Palade body exocytosis. , 2005, Trends in cardiovascular medicine.

[27]  L. Schofield,et al.  Immunological processes in malaria pathogenesis , 2005, Nature Reviews Immunology.

[28]  Kamolrat Silamut,et al.  Estimation of the Total Parasite Biomass in Acute Falciparum Malaria from Plasma PfHRP2 , 2005, PLoS medicine.

[29]  C. Lowenstein,et al.  A Novel Class of Fusion Polypeptides Inhibits Exocytosis , 2005, Molecular Pharmacology.

[30]  Thomas Hartmann,et al.  Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2. , 2004, Cancer cell.

[31]  M. Molyneux,et al.  Circulating endothelial microparticles in malawian children with severe falciparum malaria complicated with coma. , 2004, JAMA.

[32]  H. Augustin,et al.  The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. , 2004, Blood.

[33]  Wenjiang J. Fu,et al.  Erratum: Differentiating the pathologies of cerebral malaria by post-mortem parasite counts (Nature Medicine (2004) 10 (143-145)) , 2004 .

[34]  T. Mayadas,et al.  Pathogenic role of P-selectin in experimental cerebral malaria: importance of the endothelial compartment. , 2004, The American journal of pathology.

[35]  S. Satpathy,et al.  Severe falciparum malaria , 2004, Indian journal of pediatrics.

[36]  Wenjiang J. Fu,et al.  Differentiating the pathologies of cerebral malaria by postmortem parasite counts , 2004, Nature Medicine.

[37]  M. Yamakuchi,et al.  Nitric Oxide Regulates Exocytosis by S-Nitrosylation of N-ethylmaleimide-Sensitive Factor , 2003, Cell.

[38]  T. Shapiro,et al.  Immune mimicry in malaria: Plasmodium falciparum secretes a functional histamine-releasing factor homolog in vitro and in vivo , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Hyung Jin Kim,et al.  Vascular Endothelial Growth Factor Expression of Intercellular Adhesion Molecule 1 (ICAM-1), Vascular Cell Adhesion Molecule 1 (VCAM-1), and E-selectin through Nuclear Factor-κB Activation in Endothelial Cells* , 2001, The Journal of Biological Chemistry.

[40]  S. Powell,et al.  Pharmacokinetics and Pharmacodynamics of Intravenous Artesunate in Severe Falciparum Malaria , 2001, Antimicrobial Agents and Chemotherapy.

[41]  N. Day,et al.  The pathophysiologic and prognostic significance of acidosis in severe adult malaria , 2000, Critical care medicine.

[42]  N. Day,et al.  The prognostic and pathophysiologic role of pro- and antiinflammatory cytokines in severe malaria. , 1999, The Journal of infectious diseases.

[43]  K. Suzuma,et al.  Hypoxia and Vascular Endothelial Growth Factor Selectively Up-regulate Angiopoietin-2 in Bovine Microvascular Endothelial Cells* , 1999, The Journal of Biological Chemistry.

[44]  R Bicknell,et al.  Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. , 1997, The Journal of clinical investigation.

[45]  N. Anstey,et al.  Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression , 1996, The Journal of experimental medicine.

[46]  N. White,et al.  A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria. , 1996, The New England journal of medicine.

[47]  P. Gerold,et al.  Glycosylphosphatidylinositol toxin of Plasmodium up-regulates intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin expression in vascular endothelial cells and increases leukocyte and parasite cytoadherence via tyrosine kinase-dependent signal transduction. , 1996, Journal of immunology.

[48]  T. Theander,et al.  Increased plasma concentrations of sICAM-1, sVCAM-1 and sELAM-1 in patients with Plasmodium falciparum or P. vivax malaria and association with disease severity. , 1994, Immunology.

[49]  Davis,et al.  An immunohistochemical study of the pathology of fatal malaria. Evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration. , 1994, The American journal of pathology.

[50]  C. Facer,et al.  Elevated Plasma Levels of P‐Selectin (GMP‐140/CD62P) in Patients with Plasmodium falciparum Malaria , 1994, Microbiology and immunology.

[51]  M. Molyneux,et al.  Tumor necrosis factor and disease severity in children with falciparum malaria. , 1989, The New England journal of medicine.

[52]  J. Philpott,et al.  Severe falciparum malaria. , 1987, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[53]  N. White,et al.  Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration. , 1985, The American journal of pathology.